Revenue
2023
2024
2025
2026
Autonomix Medical, Inc. (AMIX)
Price$4.25Cached quote
Net income
2023
2024
2025
2026
Free cash flow
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $7.1M | $4.7M | $2.2M | $745,000 |
| Operating expenses | $17.0M | $11.6M | $12.0M | $2.0M |
| Operating income | −$17.0M | −$11.6M | −$12.0M | −$2.0M |
| EBITDA | −$17.0M | −$11.4M | −$11.9M | −$2.0M |
| Net income | −$16.7M | −$11.4M | −$15.4M | −$2.0M |
| Basic EPSper basic share | -$2.32 | -$6.46 | -$14.82 | -$3.40 |
| Diluted EPSper diluted share | -$48.72 | -$135.66 | -$311.22 | -$39.58 |
Owners
Reported shareholders
9.25%of listed shares
Mariner, LLC50.14K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Mariner, LLC | 9.25%50.14K shares |
Allied Private Wealth LLC | 0.06%347 shares |
Tower Research Capital LLC (TRC) | 0.06%313 shares |
PNC Financial Services Group, Inc. | 0.01%75 shares |
Investors Research Corp | <0.01%8 shares |
Networth Advisors, LLC | <0.01%1 shares |
Percentages use 542.31K shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2024Form 4 | Robins David AndrewDirector | BuyWarrant (Right to buy) · derivative · indirect | 104.0K | $0.00 | $0.00 | 110.2K |